Suppression of Lipopolysaccharide-induced Antiviral Transcription Factor (STAT-1 and NF-kappa B) Complexes by Antibody-dependent Enhancement of Macrophage Infection by Ross River Virus

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2002 Oct 5

PMID 12364588

Citations 39

Authors

Surendran Mahalingam

Brett A Lidbury

Affiliations

Soon will be listed here.

Abstract

Subneutralizing concentrations of antibody may enhance virus infection by bringing the virus-antibody complex into contact with the cell surface Fc receptors; this interaction facilitates entry of virus into the cell and is referred to as antibody-dependent enhancement (ADE) of infection. Northern analysis of macrophage RNA demonstrated that ADE infection by the indigenous Australian alphavirus Ross River (RRV-ADE) ablated or diminished message for tumor necrosis factor alpha (TNF-alpha), nitric-oxide synthase 2 (NOS2), and IFN regulatory factor 1 (IRF-1), as well as for IFN-inducible protein 10 (IP-10) and IFN-beta; the transcription of a control gene was unaffected. Additionally, electrophoretic mobility-shift assay (EMSA) studies showed that transcription factor IFN-alpha-activated factor (AAF), IFN-stimulated gene factor 3 (ISGF3), and nuclear factor-kappaB (NF-kappaB) complex formation in macrophage nuclear extracts were specifically suppressed post-RRV-ADE infection, emphasizing the capacity for ADE infections to compromise antiviral responses at the transcriptional level. The suppression of antiviral transcription factor complexes was shown to depend on replicating virus and was not simply a result of general antibody-Fc-receptor interaction. Although only a minority of cells ( approximately 15%) were shown to be positive for RRV by immunostaining techniques post ADE, molecular (RT-PCR) analysis showed that unstained cells carried RRV-RNA, indicating a higher level of viral infectivity than previously suspected. Electron microscopy studies confirmed this observation. Furthermore, levels of cellular IL-10 protein were dramatically elevated in RRV-ADE cultures. This evidence demonstrates that RRV can potently disrupt the activation of specific antiviral pathways via ADE infection pathways, and may suggest a significant mechanism in the infection and pathogenesis of other ADE viruses.

Citing Articles

Nonreciprocity in CHIKV and MAYV Vaccine-Elicited Protection.

Weber W, Andoh T, Kreklywich C, Streblow Z, Denton M, Streblow M Vaccines (Basel). 2024; 12(9).

PMID: 39340002 PMC: 11435824. DOI: 10.3390/vaccines12090970.

Non-infectious immune complexes downregulate the production of interferons and tumor necrosis factor-α in primary porcine alveolar macrophages .

Zhang L, Feng X, Chen W, Wang B, He S, Fan H Front Vet Sci. 2024; 11:1420466.

PMID: 38962699 PMC: 11221350. DOI: 10.3389/fvets.2024.1420466.

A Review: Understanding Molecular Mechanisms of Antibody-Dependent Enhancement in Viral Infections.

Sawant J, Patil A, Kurle S Vaccines (Basel). 2023; 11(7).

PMID: 37515055 PMC: 10384352. DOI: 10.3390/vaccines11071240.

Immune-checkpoint expression in antigen-presenting cells (APCs) of cytomegaloviruses infection after transplantation: as a diagnostic biomarker.

Aghbash P, Rasizadeh R, Arefi V, Nahand J, Baghi H Arch Microbiol. 2023; 205(8):280.

PMID: 37430000 DOI: 10.1007/s00203-023-03623-8.

Angiotensin II and dengue.

Mosquera-Sulbaran J, Pedreanez A, Hernandez-Fonseca J, Hernandez-Fonseca H Arch Virol. 2023; 168(7):191.

PMID: 37368044 DOI: 10.1007/s00705-023-05814-6.

References

Talon J, Horvath C, POLLEY R, Basler C, Muster T, Palese P . Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol. 2000; 74(17):7989-96. PMC: 112330. DOI: 10.1128/jvi.74.17.7989-7996.2000. View

Smith G . Vaccinia virus immune evasion. Immunol Lett. 1999; 65(1-2):55-62. DOI: 10.1016/s0165-2478(98)00125-4. View

Rowell J, Griffin D . The inflammatory response to nonfatal Sindbis virus infection of the nervous system is more severe in SJL than in BALB/c mice and is associated with low levels of IL-4 mRNA and high levels of IL-10-producing CD4+ T cells. J Immunol. 1999; 162(3):1624-32. View

PORTERFIELD J . Antibody-dependent enhancement of viral infectivity. Adv Virus Res. 1986; 31:335-55. DOI: 10.1016/s0065-3527(08)60268-7. View

Morens D, Halstead S . Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies. J Gen Virol. 1990; 71 ( Pt 12):2909-14. DOI: 10.1099/0022-1317-71-12-2909. View

Gao J, Filla M, Fultz M, Vogel S, RUSSELL S, Murphy W . Autocrine/paracrine IFN-alphabeta mediates the lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene. J Immunol. 1998; 161(9):4803-10. View

Wang P, Wu P, Siegel M, Egan R, Billah M . Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem. 1995; 270(16):9558-63. DOI: 10.1074/jbc.270.16.9558. View

Davis-Poynter N, Farrell H . Masters of deception: a review of herpesvirus immune evasion strategies. Immunol Cell Biol. 1996; 74(6):513-22. DOI: 10.1038/icb.1996.84. View

Moore K, de Waal Malefyt R, Coffman R, OGarra A . Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001; 19:683-765. DOI: 10.1146/annurev.immunol.19.1.683. View

10.

Way S, Lidbury B, Banyer J . Persistent Ross River virus infection of murine macrophages: an in vitro model for the study of viral relapse and immune modulation during long-term infection. Virology. 2002; 301(2):281-92. DOI: 10.1006/viro.2002.1587. View

11.

Yang K, Yeh W, Yang M, Chen R, Shaio M . Antibody-dependent enhancement of heterotypic dengue infections involved in suppression of IFNgamma production. J Med Virol. 2001; 63(2):150-7. View

12.

Basler C, Wang X, Muhlberger E, Volchkov V, Paragas J, Klenk H . The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A. 2000; 97(22):12289-94. PMC: 17334. DOI: 10.1073/pnas.220398297. View

13.

Peiris J, Gordon S, Unkeless J, PORTERFIELD J . Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages. Nature. 1981; 289(5794):189-91. DOI: 10.1038/289189a0. View

14.

Ochiai H, Kurokawa M, Matsui S, Yamamoto T, Kuroki Y, Kishimoto C . Infection enhancement of influenza A NWS virus in primary murine macrophages by anti-hemagglutinin monoclonal antibody. J Med Virol. 1992; 36(3):217-21. DOI: 10.1002/jmv.1890360312. View

15.

Ito S, Ansari P, Sakatsume M, Dickensheets H, Vazquez N, Donnelly R . Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1. Blood. 1999; 93(5):1456-63. View

16.

Tone M, Powell M, Tone Y, Thompson S, Waldmann H . IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3. J Immunol. 2000; 165(1):286-91. DOI: 10.4049/jimmunol.165.1.286. View

17.

Vrati S, Faragher S, Weir R, Dalgarno L . Ross River virus mutant with a deletion in the E2 gene: properties of the virion, virus-specific macromolecule synthesis, and attenuation of virulence for mice. Virology. 1986; 151(2):222-32. DOI: 10.1016/0042-6822(86)90044-9. View

18.

Dignam J, Lebovitz R, Roeder R . Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983; 11(5):1475-89. PMC: 325809. DOI: 10.1093/nar/11.5.1475. View

19.

Bergmann M, Garcia-Sastre A, Carnero E, Pehamberger H, Wolff K, Palese P . Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol. 2000; 74(13):6203-6. PMC: 112122. DOI: 10.1128/jvi.74.13.6203-6206.2000. View

20.

Hawkes R . ENHANCEMENT OF THE INFECTIVITY OF ARBOVIRUSES BY SPECIFIC ANTISERA PRODUCED IN DOMESTIC FOWLS. Aust J Exp Biol Med Sci. 1964; 42:465-82. DOI: 10.1038/icb.1964.44. View